Curnutte John T 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Curnutte John T
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-16+15,000→ 15,000 totalExercise: $6.80Exp: 2032-06-15→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters beginning October 1st and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 16, 2022 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.